Clinical trial

Assessment of Probiotics on Inflammation and Metabolism in Type 2 Diabetes.

NCT06440486

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-06-15

PhaseNA

Study timeline

Study start (estimated)2024-06-15Date precision: day

Registry last updated2024-06-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

ProbioticsDIETARY_SUPPLEMENT

Sponsors & collaborators

Wecare Probiotics Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06440486 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.